Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025)
Adma Biologics (ADMA) FCF Margin Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15,064.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 723.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1,409.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Adma Biologics | 1.99 Bn | 1.91 Bn | 88.82 Mn | 4,709.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4,709.00 |
| Sep 30, 2025 | 3,976.00 |
| Jun 30, 2025 | 3,770.00 |
| Mar 31, 2025 | 7,792.00 |
| Dec 31, 2024 | 10,790.00 |
| Sep 30, 2024 | 9,834.00 |
| Jun 30, 2024 | 24,669.00 |
| Mar 31, 2024 | 21,750.00 |
| Dec 31, 2023 | 27,884.00 |
| Sep 30, 2023 | 27,039.00 |
| Jun 30, 2023 | 31,531.00 |
| Mar 31, 2023 | 23,270.00 |
| Dec 31, 2022 | 15,477.00 |
| Sep 30, 2022 | 31,392.00 |
| Jun 30, 2022 | 24,563.00 |
| Mar 31, 2022 | 30,888.00 |
| Dec 31, 2021 | 41,595.00 |
| Sep 30, 2021 | 22,362.00 |
| Jun 30, 2021 | 12,735.00 |
| Mar 31, 2021 | 20,084.00 |